Sistemic
Ltd, a fast growing company focused on providing innovative
microRNA-based (miRNA) problem-solving services to areas of unmet need
within the Cell Therapy/Regenerative Medicine markets and pharmaceutical
and biotechnology R&D, is delighted to announce they have joined
the Alliance for Regenerative Medicine (ARM). Founded in 2009, the
Alliance has more than 80 members, who span research institutes,
foundations, companies and investor groups. Their aim is to advance regenerative medicine by representing and supporting members in front of government agencies and the general public.
Sistemic
is committed to the regenerative medicine sector and believe ARM has a
key role in this exciting area. Support from Sistemic will include
access to their cell characterization knowledge, innovative tools and
experience for ARM members and also the broader community. Sistemic is
confident that their miRNA profiling technology will make a significant
contribution to the advancement of cell and regenerative therapies as
well as to those developing stem cell lines for drug discovery and
development.
Verna
McErlane, Director of Commercial Operations, International at Sistemic
Ltd, comments: "The revolution promised by cell-based techniques and
therapies that regenerate cells, organs and tissues is a key area where
Sistemic is making a contribution. Our customers are looking for tools
to help them overcome the challenges of commercialisation
of cell-based or derived products - namely, the absence of robust and
information-rich characterisation and QC methods to monitor cells easily
and effectively. Sistemic's core expertise, the SistemQC
TM product, reduces these hurdles, providing an approach that fits seamlessly within their current workflow."
SistemQC™
combines
robust miRNA profiling with superior statistical analytics and
multi-layered contextual analysis to generate a fingerprint of key
miRNAs (kmiRs) providing a succinct read out on the status of the cells, with the added benefit of being able to interpret the underlying biological effects associated with any change observed.
These kmiR fingerprints can be adapted to a QPCR method for ease of
integration into laboratory routine, and provide rapid testing. The
result? Global understanding of cell systems allowing informed decision
making for companies, at critical points within their process workflows,
allowing them to proceed confidently with their cell populations.
Morrie Ruffin, Managing Director of ARM, said: "We
are delighted that Sistemic have joined ARM and look forward to sharing
information and understanding as we work together towards advancing the
field of regenerative medicine... we feel Sistemic has a great deal to
offer the Alliance in helping to support and develop this sector ."
For more information about Sistemic products and services, visit:
www.sistemic.co.uk
Sistemic, SistemRNA and SistemQC™ are registered trademarks of Sistemic UK
Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!
Request your free copies HERE
Popular this Month
Top 10 most popular articles this month
Today's Picks
Looking for a Supplier?
Search by company or by product
Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.
Lab Bulletin is published by newleaf marketing communications ltd.